The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • ECS Botanics (ECS) launches the sale of two assets and secures a new loan facility
  • The company agrees to sell its hemp food and wellness business for $250,000 to Ananda Food and plans to sell its Tasmanian medicinal cannabis facility
  • To bolster its funds further, ECS secures a $2 million commercial loan facility with NAB
  • The non-dilutive funds will be used to expand medicinal cannabis production, with the goal of boosting future revenue
  • Shares in the company are steady on the market and are trading at 2.7 cents at 10:43 am AEST

Medicinal cannabis company, ECS Botanics (ECS) has launched the sale of two assets and secured a new loan facility.

The company agreed to sell its hemp food and wellness business for $250,000 to Ananda Food, with contract completion expected in August upon the finalisation of due diligence.

In addition, the company has planned to sell its Tasmanian medicinal cannabis facility, noting a high level of interest.

To bolster its funds further, ECS secured a $2 million commercial loan facility with NAB.

The non-dilutive funds received through the sales and loan will be used to expand medicinal cannabis production, with the goal of boosting future revenue.

Managing Director Nan-Maree Schoerie said she was pleased with how operations were progressing.

“The company is about to commence the stage three expansion which will look to double the secure cultivation area and the installation of more protective cropping capacity leveraging the available funds,” she said.

“Deploying the most appropriate funding maximises value and returns for our shareholders.”

Shares in the company were steady on the market, trading at 2.7 cents at 10:43 am AEST.

ECS by the numbers
More From The Market Online
The Market Online Video

Market Close: Consumer stocks drag market lower; Alara starts copper production in Oman

The ASX200 has closed the day down 0.15 per cent at 7724 points.
The Market Online Video

Orcoda welcomes Maree Adshead as Non-Executive Director

Orcoda (ASX:ODA) has welcomed Maree Adshead as an independent Non-Executive Director.

Cynata Therapeutics advances Phase 2 trial for high-risk aGvHD treatment

The market has responded favourably to Cynata Therapeutics' announcement regarding its Phase 2 clinical trial on…
The Market Online Video

Market Update: ASX trades flat as materials leads the market

The ASX200 is trading flat this afternoon, up just .10 of a per cent in line…